CS
SNY icon

Candriam SCA’s Sanofi SNY Stock Holding History

Candriam SCA’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23
Closed -$1K – 823
2022
Q1 		$1K Buy
+23
New +$1.19K ﹤0.01% 804
2021
Q2 		– Sell
-70,048
Closed -$3.27M – 937
2021
Q1 		$3.27M Sell
70,048
-66
-0.1% -$3.17K 0.03% 444
2020
Q4 		$3.41M Buy
70,114
+9,966
+17% +$492K 0.03% 454
2020
Q3 		$3.02M Buy
60,148
+8,916
+17% +$459K 0.03% 439
2020
Q2 		$2.62M Buy
51,232
+51,212
+256,060% +$2.49M 0.03% 443
2020
Q1 		$1K Buy
+20
New +$957 ﹤0.01% 789
2019
Q1 		– Sell
-31
Closed -$1K – 830
2018
Q4 		$1K Sell
31
-1
-3% -$44 ﹤0.01% 801
2018
Q3 		$1K Buy
32
+6
+23% +$256 ﹤0.01% 804
2018
Q2 		$1K Buy
+26
New +$1.02K ﹤0.01% 781

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Candriam SCA's SNY Position: Q2 2022 in Review

Candriam SCA sold out of Sanofi (SNY) in Q2 2022, closing a stake of 23 shares — an estimated $1K sold.

Candriam SCA first reported a position in SNY in Q2 2018 and held it in 9 quarters. The position peaked at $3.41M in Q4 2020. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

  • Candriam SCA reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
  • Candriam SCA sold 23 Sanofi shares in Q2 2022, an estimated $1K.
  • Candriam SCA first reported a position in Sanofi in Q2 2018 and held it in 9 quarters.
  • Candriam SCA's Sanofi position peaked at $3.41M in Q4 2020.
  • 656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.